Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence.
Blood pressure
Hypertension
Renal denervation
Journal
Cardiology and therapy
ISSN: 2193-8261
Titre abrégé: Cardiol Ther
Pays: England
ID NLM: 101634495
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
23
06
2022
accepted:
22
07
2022
pubmed:
10
8
2022
medline:
10
8
2022
entrez:
9
8
2022
Statut:
ppublish
Résumé
Evidence from recent sham-controlled trials supports the use of endovascular renal denervation (RDN) to lower blood pressure in general as well as in treatment-resistant hypertension. According to recent studies, the effects of RDN are long lasting. Newer technologies using multipolar radiofrequency catheters and an additional ablation of the renal side branches as well as ultrasound with improved circumferential tissue penetration have made these advances possible. This has initiated a change of the perspective on RDN in clinical guidelines and has thereby set a cornerstone for a broader clinical application of RDN in the future.
Identifiants
pubmed: 35943714
doi: 10.1007/s40119-022-00275-5
pii: 10.1007/s40119-022-00275-5
pmc: PMC9381663
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
385-392Informations de copyright
© 2022. The Author(s).
Références
J Hypertens. 2015 Dec;33(12):2526-33
pubmed: 26378683
Lancet. 2020 May 2;395(10234):1444-1451
pubmed: 32234534
J Am Heart Assoc. 2020 Sep;9(17):e017634
pubmed: 32851922
Hypertension. 2004 Feb;43(2):169-75
pubmed: 14610101
Ann Anat. 2016 Mar;204:71-9
pubmed: 26617159
J Am Heart Assoc. 2021 Nov 2;10(21):e022429
pubmed: 34713718
N Engl J Med. 2014 Apr 10;370(15):1393-401
pubmed: 24678939
JACC Cardiovasc Interv. 2020 Feb 24;13(4):471-484
pubmed: 32081241
Br Heart J. 1958 Apr;20(2):249-52
pubmed: 13523020
Am Heart J. 2021 Sep;239:90-99
pubmed: 34052211
Am J Physiol Regul Integr Comp Physiol. 2005 Sep;289(3):R633-41
pubmed: 16105818
EuroIntervention. 2020 May 20;16(1):89-96
pubmed: 32038027
Hypertension. 2015 Apr;65(4):766-74
pubmed: 25691618
Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
Am J Hypertens. 2015 Mar;28(3):355-61
pubmed: 25156625
Lancet. 2018 Jun 9;391(10137):2335-2345
pubmed: 29803590
Circulation. 2019 Jan 29;139(5):590-600
pubmed: 30586691
J Hypertens. 2015 Feb;33(2):195-211
pubmed: 25485720
Lancet. 2017 Nov 11;390(10108):2160-2170
pubmed: 28859944
J Hypertens. 2021 Sep 1;39(9):1733-1741
pubmed: 34261957
J Am Heart Assoc. 2017 Aug 10;6(8):
pubmed: 28862930
Lancet. 2015 Nov 21;386(10008):2059-2068
pubmed: 26414968
Eur Heart J. 2019 Nov 1;40(42):3474-3482
pubmed: 30907413
Lancet. 2018 Jun 9;391(10137):2346-2355
pubmed: 29803589
J Clin Invest. 1937 Jan;16(1):49-65
pubmed: 16694459
Am J Hypertens. 2005 Nov;18(11):1422-8
pubmed: 16280275
Hypertension. 2016 Aug;68(2):297-306
pubmed: 27296995
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Circulation. 2021 Oct 12;144(15):1212-1226
pubmed: 34565172
Hypertension. 2018 Apr;71(4):681-690
pubmed: 29463627
Lancet. 2021 Jun 26;397(10293):2476-2486
pubmed: 34010611
J Am Coll Cardiol. 2020 Jun 16;75(23):2879-2888
pubmed: 32527396
JACC Cardiovasc Interv. 2016 Mar 28;9(6):589-98
pubmed: 27013159
N Engl J Med. 2021 Dec 30;385(27):2507-2519
pubmed: 34739197
J Am Coll Cardiol. 2015 Oct 20;66(16):1766-1775
pubmed: 26483099
J Exp Med. 1928 Jan 1;47(1):105-14
pubmed: 19869390
J Am Med Assoc. 1953 Aug 15;152(16):1501-4
pubmed: 13061307
Lancet. 2022 Apr 9;399(10333):1401-1410
pubmed: 35390320
J Hypertens. 2017 Feb;35(2):369-375
pubmed: 28005705